Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhG-CSF injection vs Neulastim for prevention of chemotherapy-induced neutropenia in breast cancer
CTR20200921Phase 3Completed
- Sponsor
- Jiuyuan Gene Engineering
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Jiuyuan Gene Engineering. Started Nov 2020; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20200921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200921.